Login / Signup

Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study.

Sarah E HughesChristel M McMullanAnna RoweAmeeta RetzerRebecca MalpassCamilla BathurstElin Haf DaviesChris FrostGary McNamaraRosie HardingGary PriceRoger WilsonAnita WalkerPhilip N NewsomeMelanie Jane Calvert
Published in: BMJ open (2022)
ISRCTN80103507.
Keyphrases
  • patient reported outcomes
  • clinical trial
  • randomized controlled trial
  • oxidative stress
  • phase ii
  • open label
  • stem cells
  • mesenchymal stem cells
  • cell therapy
  • bone marrow